Furthermore, we identified an association between karyotype abnormalities and TP53 mutations, with poorer outcomes in CMML patients; however, these associations were only significant for RUNX1 and TP53 in multivariate analysis. The gene discussed is RUNX1; the disease is chronic myelomonocytic leukemia.